Related Experiment Video
Updated: Jul 8, 2025
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Glucocorticoid reduction induced chorea in pediatric-onset systemic lupus erythematosus: A case report
Yan-Qiu Xu1, Miao Wang1, Ying Zhang2
1Department of Rheumatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China.
Background:
Pediatric-onset systemic lupus erythematosus (SLE) is typically more severe than adult-onset SLE, with a higher incidence of nervous system involvement. Chorea is a relatively rare neurological complication reported in 2.4%-7% of SLE patients. In particular, chorea induced by glucocorticoid dose reduction is even rarer. Herein, we report the case of a girl with SLE, who developed chorea during the process of glucocorticoid therapy reduction.
Case Summary:
We describe a 14-year-old girl who was diagnosed with SLE. She was treated with methylprednisolone and rituximab, and her symptoms improved. On the second day after the methylprednisolone dose was reduced according to the treatment guidelines, the patient developed chorea. Her condition improved after adjusting her glucocorticoid regimen.
Conclusion:
This case is a reminder that extra attention to chorea is required in SLE patients during glucocorticoid dose reduction.
